SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Peter Singleton who wrote (3524)1/4/1998 11:42:00 PM
From: Steve Fancy  Respond to of 6136
 
Anyone catch the 2878 Feb 30 puts that traded Friday? We'll have to watch the open interest to see if folks were cashing out or opening positions. Hopefully someone in the know selling 30 puts.

sf



To: Peter Singleton who wrote (3524)1/4/1998 11:43:00 PM
From: billkirn  Read Replies (2) | Respond to of 6136
 
Peter: Thanks for your estimates. I wonder if these revenue figures would indicate an upward move for the stock. I'm not sure if the stock will be trading to a PE ratio or on expectations of new products. I think you are in a range +_ 10% of what will happen with Viracept and maybe other business ventures can improve these numbers.
Investors are concerned that AGPH is a one drug wonder, so it is really important they demonstrate their technology can produce other successful drugs. 1998 could be the year this will happen.
Bill